In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
暂无分享,去创建一个
S. H. van der Burg | J. Drijfhout | W. Kast | C. V. D. van de Velde | P. Kenemans | F. Momburg | H. Nijman | C. Melief | A. Brand | J. Houbiers | Anneke Brand | C. J. van de Velde
[1] S. H. van der Burg,et al. Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes , 1993, European journal of immunology.
[2] M. Mamula. The inability to process a self-peptide allows autoreactive T cells to escape tolerance , 1993, The Journal of experimental medicine.
[3] M. Aidoo,et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.
[4] L. Berg,et al. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides , 1992, European journal of immunology.
[5] K. Parker,et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. , 1992, Journal of immunology.
[6] P. Cresswell,et al. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules , 1992, Nature.
[7] J. Neefjes,et al. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation , 1992, Nature.
[8] T. Schumacher,et al. Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responses , 1992, European journal of immunology.
[9] Z. Grossman,et al. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] Klas Kärre,et al. Assessment of major histocompatibility complex class I interaction with Epstein‐Barr virus and human immunodeficiency virus peptides by elevation of membrane H‐2 and HLA in peptide loading‐deficient cells , 1992, European journal of immunology.
[11] B. Chain,et al. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[13] A. Levine,et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[15] E. Sercarz,et al. In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment , 1992, The Journal of experimental medicine.
[16] W. Kast,et al. Cytotoxic T lymphocytes against the antigen‐processing‐defective RMA‐S tumor cell line , 1992, European journal of immunology.
[17] S. Ohno. How cytotoxic T cells manage to discriminate nonself from self at the nonapeptide level. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Thorsby,et al. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. , 1992, Human immunology.
[19] R. Moots,et al. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytes , 1992, European journal of immunology.
[20] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[21] R. Demars,et al. New genes in the MHC that encode proteins for antigen processing. , 1992, Trends in cell biology.
[22] C. Melief,et al. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. , 1992, Advances in cancer research.
[23] T. Boon,et al. Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] T. Boon. Toward a genetic analysis of tumor rejection antigens. , 1992, Advances in cancer research.
[25] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[26] T. Schumacher,et al. Peptide loading of empty major histocompatibility complex molecules on RMA‐S cells allows the induction of primary cytotoxic T lymphocyte responses , 1991, European journal of immunology.
[27] Peter Walden,et al. Exact prediction of a natural T cell epitope , 1991, European journal of immunology.
[28] E. Pamer,et al. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.
[29] A. Belldegrun,et al. Autologous Tumor-Specific Cytotoxicity of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[30] M. Luscher,et al. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.
[31] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[32] E. Sercarz,et al. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. , 1991, Immunology today.
[33] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[34] Hidde L. Ploegh,et al. Peptide selection by MHC class I molecules , 1991, Nature.
[35] J. Connolly,et al. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes , 1991, The Journal of experimental medicine.
[36] H. Schluesener,et al. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins , 1991, The Journal of experimental medicine.
[37] P. Greenberg. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.
[38] Hidde L. Ploegh,et al. Empty MHC class I molecules come out in the cold , 1990, Nature.
[39] T. Soussi,et al. Structural aspects of the p53 protein in relation to gene evolution. , 1990, Oncogene.
[40] P. Cresswell,et al. Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.
[41] H. Rammensee,et al. Limit of T cell tolerance to self proteins by peptide presentation. , 1990, Science.
[42] H. Mcdevitt,et al. T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides. , 1990, International reviews of immunology.
[43] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[44] R. Offringa,et al. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes , 1989, Cell.
[45] H. Ljunggren,et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.
[46] B. Askonas,et al. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro , 1989, The Journal of experimental medicine.
[47] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[48] F Gotch,et al. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site , 1988, The Journal of experimental medicine.
[49] J. Cerottini,et al. Antigen recognition by H‐2‐restricted cytolytic T lymphocytes: inhibition of cytolysis by anti‐CDS monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen , 1988, European journal of immunology.
[50] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[51] G. Pantaleo,et al. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function , 1984, The Journal of experimental medicine.
[52] D. Pim,et al. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer , 1982, International journal of cancer.